INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | 0.0% | 4,002 | -7.1% | 0.00% | 0.0% |
Q2 2023 | $2 | -33.3% | 4,306 | +6.2% | 0.00% | -33.3% |
Q1 2023 | $3 | -81.2% | 4,053 | -58.1% | 0.00% | -57.1% |
Q4 2022 | $16 | -99.8% | 9,680 | +92.7% | 0.01% | -12.5% |
Q3 2022 | $9,000 | 0.0% | 5,024 | -0.1% | 0.01% | +14.3% |
Q2 2022 | $9,000 | -60.9% | 5,028 | -23.0% | 0.01% | -53.3% |
Q1 2022 | $23,000 | -45.2% | 6,528 | -21.8% | 0.02% | -74.6% |
Q4 2021 | $42,000 | – | 8,347 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |